Online citations, reference lists, and bibliographies.
← Back to Search

Magnetic Targeting For Site-specific Drug Delivery: Applications And Clinical Potential

B. Polyak, G. Friedman
Published 2009 · Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
Background: Magnetic vehicles are very attractive for delivery of therapeutic agents as they can be targeted to specific locations in the body through the application of a magnetic field gradient. The magnetic localization of a therapeutic agent results in the concentration of the therapy at the target site consequently reducing or eliminating the systemic drug side effects. Objective: The aim of this review is to provide an update on the progress made in the development of the magnetic targeting technique addressing characteristics of the magnetic carriers and limitations of the current targeting magnet systems. Methods: This review discusses fundamental requirements for the optimal formulation of the magnetic carrier, current applications and potentially new approaches for the magnetically mediated, site-specific localization of therapeutic agents, including drugs, genes and cells. Results/conclusion: More efficient targeting magnetic systems in combination with prolonged circulation lifespan and carriers' surface recognition properties will improve the targeting efficiency of magnetic nanocarriers and enhance therapeutic agent availability at the molecular site of agent action. The main future magnetic targeting applications were categorized emphasizing the most promising directions and possible strategies for improving the magnetic targeting technique.
This paper references
Magnetizable needles and wires--modeling an efficient way to target magnetic microspheres in vivo.
Gh Iacob (2004)
10.1517/14712598.3.5.745
Enhancing and targeting nucleic acid delivery by magnetic force
C. Plank (2003)
10.1042/BJ20031253
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
10.1002/JSSC.200700088
Preparation and properties of magnetic nano- and microsized particles for biological and environmental separations.
D. Horák (2007)
10.1073/PNAS.78.1.579
Tumor remission in Yoshida sarcoma-bearing rts by selective targeting of magnetic albumin microspheres containing doxorubicin.
K. Widder (1981)
Very interesting article demonstrating that magnetic forces can be used to rapidly place endothelial cells at the site of a permanently magnetized intravascular stent
10.1097/00000658-195710000-00007
Selective Inductive Heating of Lymph Nodes
R. Gilchrist (1957)
10.1016/J.JACC.2006.06.069
Magnetically targeted endothelial cell localization in stented vessels.
S. Pislaru (2006)
10.1038/sj.gt.3300867
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer
D. Lechardeur (1999)
10.1002/(SICI)1097-4636(19980305)39:3<478::AID-JBM19>3.0.CO;2-6
Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics.
M. Lück (1998)
10.1080/02652040500435444
Magnetic PECA nanoparticles as drug carriers for targeted delivery: Synthesis and release characteristics
J. Yang (2006)
10.1201/9781420004441.CH29
Magnetic Nanoparticles as Contrast Agents for Medical Diagnosis
L. Tiefenauer (2007)
10.1038/nature04090
Microscopic artificial swimmers
R. Dreyfus (2005)
10.1073/pnas.0708338105
High field gradient targeting of magnetic nanoparticle-loaded endothelial cells to the surfaces of steel stents
B. Polyak (2008)
10.1056/NEJM197101282840402
Stereotactic thrombosis of intracranial aneurysms.
J. Alksne (1970)
10.1016/S0304-8853(02)00605-4
Magnetic drug targeting: biodistribution and dependency on magnetic field strength ☆
Ch. Alexiou (2002)
10.1159/000073901
Magnetofection Potentiates Gene Delivery to Cultured Endothelial Cells
F. Kroetz (2003)
10.1128/CMR.7.1.43
Magnetic separation techniques in diagnostic microbiology.
O. Olsvik (1994)
10.1016/0014-5793(79)80940-0
Preparation and application of magnetic polymers for targeting of drugs
K. Mosbach (1979)
10.1016/J.JCONREL.2006.11.031
Synthesis and characterization of highly-magnetic biodegradable poly(d,l-lactide-co-glycolide) nanospheres.
X. Liu (2007)
10.3109/03639049709149153
Magnetically Guided Rat Erythrocytes Bearing Isoniazid: Preparation, Characterization, and Evaluation
S. Jain (1997)
Japan) assignee. Manufacture of needle-like magnetic iron oxide particle powders. Application: JP, JP patent 93-193099
K Fujita (1995)
10.2741/2796
An overview of responsive MRI contrast agents for molecular imaging.
Byunghee Yoo (2008)
10.1038/sj.gt.3302395
Novel dextran–spermine conjugates as transfecting agents: comparing water-soluble and micellar polymers
H. Eliyahu (2005)
10.1016/0169-409X(95)00033-4
Long-circulating iron oxides for MR imaging
R. Weissleder (1995)
10.1109/TASC.2005.864457
A High Field Gradient Magnet for Magnetic Drug Targeting
C. Alexiou (2006)
10.1002/HEP.1840080218
Interactions between isolated hepatocytes and kupffer cells in iron metabolism: A possible role for ferritin as an iron carrier protein
J. Sibille (1988)
Clinical experiences with magnetic drug targeting: a phase I study with 4'-epidoxorubicin in 14 patients with advanced solid tumors.
A. Lübbe (1996)
10.1016/S0304-8853(98)00560-5
In vitro and in vivo toxicity of magnetic microspheres
U. Häfeli (1999)
10.1063/1.2836795
Poly(D,L-lactide-co-glycolide) microcomposite containing magnetic iron core nanoparticles as a drug carrier
Sweta H. Naik (2008)
10.1016/J.YMTHE.2005.02.010
A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy.
S. Moghimi (2005)
10.1016/J.MEHY.2003.10.003
Principles of magnetodynamic chemotherapy.
M. Babincová (2004)
10.1615/CRITREVTHERDRUGCARRIERSYST.V18.I6.30
Capture of stealth nanoparticles by the body's defences.
S. Moghimi (2001)
10.1016/S0378-5173(02)00058-3
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study.
J. Vandervoort (2002)
10.1016/J.JALLCOM.2006.08.311
Biomedical applications of superparamagnetic iron oxide nanoparticles encapsulated within chitosan
E. Kim (2007)
10.1016/J.JMMM.2005.02.055
Detoxification of blood using injectable magnetic nanospheres: A conceptual technology description
M. Kaminski (2005)
10.1021/LA0530079
Colloidal stability of magnetite/poly(lactic acid) core/shell nanoparticles.
S. A. Gómez-Lopera (2006)
Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting.
C. Alexiou (2007)
10.1016/0168-3659(95)00053-B
Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers
T. Verrecchia (1995)
10.1002/JBM.820270807
Adsorption/desorption of human serum albumin at the surface of poly(lactic acid) nanoparticles prepared by a solvent evaporation process.
T. Verrecchia (1993)
10.1109/IEMBS.2006.259818
Magnetic Steering of Iron Oxide Microparticles Using Propulsion Gradient Coils in MRI
J.-B. Mathieu (2006)
10.1126/science.7638603
Ultrasound-mediated transdermal protein delivery
S. Mitragotri (1995)
10.1088/0953-8984/18/38/S24
Drug loaded magnetic nanoparticles for cancer therapy
R. Jurgons (2006)
Magnetic guidance of drug-carrying Polyak & Friedman Expert Opin. Drug Deliv
A Senyei (1978)
inventor (University Technology Corp., USA) assignee
DCF Chan (1998)
inventors; (Toda Kogyo Corp, Japan) assignee. Manufacture of needle-like magnetic iron oxide particle powders
K Fujita (1993)
Microsphere-Mediated Delivery of Recombinant AAV Vectors In Vitro And In Vivo [abstract
C Mah (2000)
10.2174/157341308783591861
Magnetic Nanoparticles for Cancer Therapy
G. F. Goya (2008)
10.1023/A:1008933601813
Structure of dextran–magnetite complex: relation between conformation of dextran chains covering core and its molecular weight
T. Kawaguchi (2000)
10.1016/J.IJPHARM.2006.06.029
Preparation of poly ɛ-caprolactone nanoparticles containing magnetite for magnetic drug carrier
J. M. Yang (2006)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, toxicity, possibilities of targeting, and use.
J. Kreuter (1983)
10.1063/1.2921971
Stress wave attenuation in ceramic plates
N. Naik (2008)
10.1016/S0168-3659(98)00138-2
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS.
P. Scholes (1999)
10.2165/00137696-200402030-00002
Biodegradable PEGylated microspheres and nanospheres
V. Sinha (2004)
10.1109/TMAG.2003.816260
An approach to targeted drug delivery based on uniform magnetic fields
Z. G. Forbes (2003)
Magnetically controlled metallic thrombosis of intracranial aneurysms. A preliminary report.
J. Alksne (1965)
10.1016/j.addr.2012.09.004
Biodegradation and biocompatibility of PLA and PLGA microspheres.
Shive (1997)
Magnetofection: enhancement and localization of gene delivery with magnetic particles under the infl uence of a magnetic fi eld
C Plank (2000)
10.1515/BC.2003.082
The Magnetofection Method: Using Magnetic Force to Enhance Gene Delivery
C. Plank (2003)
10.1016/J.ADDR.2004.01.009
Folate receptor-targeted immunotherapy of cancer: mechanism and therapeutic potential.
Y. Lu (2004)
10.1504/IJNT.2006.011179
Applications of nanotechnology in drug delivery systems for the treatment of cancer and diabetes
K. Subramani (2006)
10.1002/ijc.20035
Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet
H. Nobuto (2004)
10.1002/ADMA.200700091
Remotely Triggered Release from Magnetic Nanoparticles
Austin M. Derfus (2007)
10.1016/J.JMMM.2005.01.083
Targeted drug delivery to magnetic implants for therapeutic applications
B. Yellen (2005)
10.1006/MTHE.2001.0636
Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.
C. Mah (2002)
10.1016/J.JMMM.2006.11.177
Encapsulation of indomethacin in magnetic biodegradable polymer nanoparticles
V. Závišová (2007)
10.1089/TEN.2005.11.1553
Novel methodology for fabrication of tissue-engineered tubular constructs using magnetite nanoparticles and magnetic force.
A. Ito (2005)
Drug release and release mechanism of prednisolone loaded Solid Lipid Nanoparticles
A. Z. Mühlen (1998)
10.1016/J.IJPHARM.2007.09.004
Suspension of Fe(3)O(4) nanoparticles stabilized by chitosan and o-carboxymethylchitosan.
Aiping Zhu (2008)
10.1109/TBME.2007.899347
Validation of High Gradient Magnetic Field Based Drug Delivery to Magnetizable Implants Under Flow
Z. G. Forbes (2008)
10.1016/S0021-9290(02)00034-9
Hydrodynamics of magnetic drug targeting.
P. A. Voltairas (2002)
10.1016/0277-5379(83)90408-X
Selective targeting of magnetic albumin microspheres containing low-dose doxorubicin: total remission in Yoshida sarcoma-bearing rats.
K. Widder (1983)
10.1002/HEP.510240341
An update on iron metabolism: Summary of the Fifth International Conference on Disorders of Iron Metabolism
H. Bonkovsky (1996)
10.1016/S1051-0443(99)70458-6
Use of endothelial cells containing superparamagnetic microspheres to improve endothelial cell delivery to arterial surfaces after angioplasty.
P. M. Consigny (1999)
10.1021/NL0618501
Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging.
M. Brähler (2006)
10.1109/TMAG.2007.894123
Synthesis of Ibuprofen Loaded Magnetic Solid Lipid Nanoparticles
X.J. Pang (2007)
10.1016/j.actbio.2008.02.002
A stimulus-responsive magnetic nanoparticle drug carrier: magnetite encapsulated by chitosan-grafted-copolymer.
Q. Yuan (2008)
10.1016/S0169-409X(97)00049-5
Preparation of microspheres by the solvent evaporation technique.
McGinity (1997)
10.1002/PROS.20576
Nanoparticulate delivery of suicide DNA to murine prostate and prostate tumors
W. Peng (2007)
10.1126/SCIENCE.8128245
Biodegradable long-circulating polymeric nanospheres.
R. Gref (1994)
10.3109/02652049809006840
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique.
D. Quintanar-Guerrero (1998)
Magnetically controlled intravascular catheter.
J. Alksne (1968)
Magnetically controlled intravascular catheter.
Alksne Jf (1968)
10.1080/1061186031000150791
Magnetic drug targeting--biodistribution of the magnetic carrier and the chemotherapeutic agent mitoxantrone after locoregional cancer treatment.
C. Alexiou (2003)
10.1109/TNANO.2007.891829
Design and Evaluation of Magnetic Fields for Nanoparticle Drug Targeting in Cancer
B. Gleich (2007)
10.1016/J.BBAMEM.2003.09.002
Intracellular dynamics of the gene delivery vehicle polyethylenimine during transfection: investigation by two-photon fluorescence correlation spectroscopy.
Jean-Pierre Clamme (2003)
10.1016/S0022-5347(17)59500-2
Ferromagnetic silicone necrosis of hypernephromas by selective vascular occlusion to the tumor: a new technique.
R. Turner (1975)
10.1163/156856299X00243
Effect of solvent on the characteristics of pentamidine loaded microcapsule.
T. Mandal (1999)
10.1385/1-59745-010-3:387
Targeted magnetic resonance imaging contrast agents.
S. Caruthers (2006)
Locoregional cancer treatment with magnetic drug targeting.
C. Alexiou (2000)
10.1016/S0927-7765(99)00156-3
'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption.
Gref (2000)
10.1016/0142-9612(84)90037-1
The in vivo and in vitro degradation of poly(glycolic acid) suture material as a function of applied strain.
N. D. Miller (1984)
10.1021/LA980703I
Permanently Linked Monodisperse Paramagnetic Chains
E. Furst (1998)
10.1148/RADIOL.2301021493
Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/ conventional angiography suite--initial experience with four patients.
M. Wilson (2004)
10.1006/JSRE.2000.6030
Clinical applications of magnetic drug targeting.
A. Lübbe (2001)
10.1007/S10544-007-9092-0
Magnetic microparticle steering within the constraints of an MRI system: proof of concept of a novel targeting approach
J. Mathieu (2007)
10.1002/JBM.820110507
Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios.
R. Miller (1977)
10.1073/PNAS.0407218101
A polymer library approach to suicide gene therapy for cancer.
D. Anderson (2004)
10.1023/A:1011922819926
Stealth PLA-PEG Nanoparticles as Protein Carriers for Nasal Administration
M. Tobío (2004)
Microscopic artifi cial swimmers
R Dreyfus (2005)
•• Fundamental study on the long circulating theory of the colloidal systems
Magnetic albumin microspheres in drug delivery
K J Widder (1984)
10.1016/S0939-6411(98)00038-1
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats.
M. Roser (1998)
Preparation of poly epsilon-caprolactone nanoparticles containing magnetite for magnetic drug carrier.
J. Yang (2006)
10.1016/J.JMMM.2004.05.022
Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible
W. Jiang (2004)
10.1016/J.IJPHARM.2003.12.029
PEI-based vesicle-polymer hybrid gene delivery system with improved biocompatibility.
A. Brownlie (2004)
10.1038/gt.2008.57
A novel magnetic approach to enhance the efficacy of cell-based gene therapies
M. Muthana (2008)
10.1016/0378-5173(93)90313-5
Solid lipospheres of doxorubicin and idarubicin
R. Cavalli (1993)
comparing water-soluble Magnetic targeting for site-specifi c drug delivery: applications and clinical potential 70 Expert Opin
H Eliyahu (2009)
• In vitro and in vivo demonstration of the ability to deliver genes using non-viral vectors associated with magnetic carriers
F Scherer (2002)
10.1038/nnano.2007.217
Targeted delivery of magnetic aerosol droplets to the lung
P. Dames (2007)
10.1089/1076327041348301
Tissue engineering using magnetite nanoparticles and magnetic force: heterotypic layers of cocultured hepatocytes and endothelial cells.
A. Ito (2004)
10.1016/j.ejpb.2007.11.002
Magnetite/poly(alkylcyanoacrylate) (core/shell) nanoparticles as 5-Fluorouracil delivery systems for active targeting.
J. L. Arias (2008)
10.1248/CPB.28.3087
Drug-carrier property of albumin microspheres in chemotherapy. IV. Antitumor effect of single-shot or multiple-shot administration of microsphere-entrapped 5-fluorouracil on Ehrlich ascites or solid tumor in mice.
Y. Morimoto (1980)
10.3181/00379727-158-40158
Magnetic Microspheres: A Model System for Site Specific Drug Delivery in Vivo 1
K. Widder (1978)
10.1002/JPS.2600840420
Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system.
D. Bazile (1995)
10.1023/A:1016096626810
Transdermal Drug Delivery Using Low-Frequency Sonophoresis
S. Mitragotri (2004)
10.1016/S0142-9612(01)00267-8
Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake.
Y. Zhang (2002)
10.1016/S0304-8853(00)01256-7
Magnetic mitoxantrone nanoparticle detection by histology, X-ray and MRI after magnetic tumor targeting
C. Alexiou (2001)
A multicenter, phase I/II trial of hepatic intra-arterial delivery of doxorubicin hydrochloride adsorbed to magnetic targeted carriers in patients with hepatocellular carcinoma
J Koda (2002)
Microsphere-Mediated Delivery of Recombinant AAV Vectors In Vitro And In Vivo
C Mah
10.1016/S0168-3659(00)00364-3
Effects of emulsifiers on the controlled release of paclitaxel (Taxol) from nanospheres of biodegradable polymers.
S. Feng (2001)
10.1038/nnano.2008.39
Remote control of cellular behaviour with magnetic nanoparticles.
J. Dobson (2008)
10.1002/JBM.820070204
Resorption rate, route, route of elimination, and ultrastructure of the implant site of polylactic acid in the abdominal wall of the rat.
J. M. Brady (1973)
10.1038/sj.gt.3301624
Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo
Friedrich Scherer (2002)
10.1002/DDR.20067
Magnetic nanoparticles for drug delivery
J. Dobson (2006)
Magnetism in medicine.
C. Breathnach (1983)
10.1212/WNL.20.4.376
Quantitative measurements of L-dopa therapy in Parkinson's disease.
Webster Dd (1969)
10989 -93 Magnetic targeting for site-specifi c drug delivery: applications and clinical potential 68 Expert Opin
Armes SP Takabayashi Y et al. Synthesis of Biocompatible Yuan JJ (2009)
applications and clinical potential 66 Expert Opin
D Quintanar-Guerrero (2009)
10.1007/s00395-008-0711-6
Contrast agents for MRI
E. A. Waters (2008)
10.1016/J.SURFCOAT.2006.01.062
Application of surface acoustic waves for optimisation of biocompatibility of carboxymethylated dextran surfaces
G. Markovic (2006)
Factors influencing the body distribution of polyacrylic nanoparticles
J. Kreuter (1985)
10.1007/978-1-4612-5182-8_22
Magnetic microcapsules for targeted delivery of anticancer drugs.
T. Kato (1984)
10.1046/J.1525-1594.1999.06278.X
Biocompatible magnetic polymer carriers for in vivo radionuclide delivery.
W. Schuett (1999)
10.1016/0378-5173(95)04388-8
Thymopentin in solid lipid nanoparticles
S. Morel (1996)
10.1248/CPB.27.204
Drug-carrier property of albumin microspheres in chemotherapy. II. Preparation and tissue distribution in mice of microsphere-entrapped 5-fluorouracil.
K. Sugibayashi (1979)
Preliminary investigation of the feasibility of magnetic propulsion for future microdevices in blood vessels.
J. Mathieu (2005)
10.3109/03639049809108571
Preparation techniques and mechanisms of formation of biodegradable nanoparticles from preformed polymers.
D. Quintanar-Guerrero (1998)
10.1016/0969-8051(94)00124-3
Effective targeting of magnetic radioactive 90Y-microspheres to tumor cells by an externally applied magnetic field. Preliminary in vitro and in vivo results.
U. Häfeli (1995)
Application: US, US patent 96-617685, 5753477
Magneto-Biolistic Methods (1998)
10.1016/0032-3861(85)90160-0
Degradation phenomena of two linear aliphatic polyester fibres used in medicine and surgery
Chih-Chang Chu (1985)
10.1007/BF00752233
Biodegradation of surgical polymers
D. Williams (1982)
10.1088/0957-4484/18/40/405102
Magnetic and fluorescent multifunctional chitosan nanoparticles as a smart drug delivery system
L. Li (2007)
10.1002/jgm.696
Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis
A. Akinc (2005)
10.1016/J.JMMM.2006.10.1170
Preparation and characterization of biodegradable magnetic carriers by single emulsion-solvent evaporation
Xianqiao Liu (2007)
10.1109/TBME.2008.919720
Real-Time MRI-Based Control of a Ferromagnetic Core for Endovascular Navigation
S. Tamaz (2008)
Magnetic and fl uorescent multifunctional chitosan nanoparticles as a smart drug delivery system
L Li (2007)
10.1016/J.BIOMATERIALS.2005.08.024
Dextran-spermine-based polyplexes--evaluation of transgene expression and of local and systemic toxicity in mice.
H. Eliyahu (2006)
10.1007/978-1-59259-167-1_20
Targeting Tumors with Magnetic Drugs
A. Lübbe (2002)
10.1006/MTHE.2001.0268
Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
C. Hughes (2001)
10.3109/02652049609026013
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
10.1002/JBM.820271108
Mechanisms of polymer degradation in implantable devices. 2. Poly(DL-lactic acid).
S. A. Ali (1993)
10.1002/JPS.2600820607
A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. I: Influence of emulsification and surfactant concentration.
B. Sjoestroem (1993)
10.1248/BPB1978.3.264
Biomedical applications of magnetic fluids. i. Magnetic guidance of ferro-colloid-entrapped albumin microsphere for site specific drug delivery in vivo.
Y. Morimoto (1980)
10.1080/02656730500158360
Clinical hyperthermia of prostate cancer using magnetic nanoparticles: Presentation of a new interstitial technique
M. Johannsen (2005)
10.1016/S0304-8853(98)00568-X
New ferro-carbon adsorbents for magnetically guided transport of anti-cancer drugs
A. Kuznetsov (1999)
Camoufl age nanospheres: A new approach to bypassing phagocytic blood clearance by surface modifi ed particulate carriers
BG Mueller (1993)
Evaluation of nanoparticles as drug-delivery systems I: preparation methods
J. Kreuter (1983)
cancer xenograft mouse model
(2007)
10.1023/A:1016216011016
Preparation and Characterization of Dextran Magnetite-Incorporated Thermosensitive Liposomes: An on-line Flow System for Quantifying Magnetic Responsiveness
E. Viroonchatapan (2004)
10.1021/BC050066P
Quaternary ammonium polysaccharides for gene delivery.
I. Yudovin-Farber (2005)
10.1080/10611860701453901
Magnetic poly ε-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic cancer xenograft mouse model
Jingu Gang (2007)
10.1517/17425247.3.1.1
Nuclear gene delivery: the Trojan horse approach
A. Rolland (2006)
10.1002/PROS.20213
Magnetic fluid hyperthermia (MFH)reduces prostate cancer growth in the orthotopic Dunning R3327 rat model
M. Johannsen (2005)
10.1002/JBM.A.31022
Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids.
S. Wan (2007)
10.1016/J.EJPB.2006.12.020
Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.
L. N. Okassa (2007)
10.1016/S0378-5173(01)00936-X
Development and characterization of solid lipid nanoparticles loaded with magnetite.
M. Igartua (2002)
The POD and its applications.
E. Frei (1966)
10.1515/znc-1976-11-1219
Organspezifische Applikation von pharmazeutisch aktiven Substanzen über zellulare Trägersysteme / Organ Specific Application of Drugs by Means of Cellular Capsule Systems
U. Zimmermann (1976)
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
A. Lübbe (1996)
Magnetic poly e-caprolactone nanoparticles containing Fe3O4 and gemcitabine enhance anti-tumor effect in pancreatic
J Gang (2009)
Functionalized magnetic nanoparticles for tissue engineering
A Ito (2007)
Colloidal Stability of Magnetite/Poly
S A Gomez-Lopera
10.1016/J.JMMM.2008.05.023
Heat generation of aqueously dispersed CoFe2O4 nanoparticles as heating agents for magnetically activated drug delivery and hyperthermia
Deok-ryeong Kim (2008)
10.1021/JP711319A
Preparation of Well-Dispersed Superparamagnetic Iron Oxide Nanoparticles in Aqueous Solution with Biocompatible N-Succinyl-O-carboxymethylchitosan
Aiping Zhu (2008)
10.1007/s00330-004-2445-7
MRI after magnetic drug targeting in patients with advanced solid malignant tumors
A. Lemke (2004)
10.1080/02726350600840696
Synthesis of Poly(DL-Lactide-Co-Glycolide) Nanoparticles with Entrapped Magnetite by Emulsion Evaporation Method
C. Astete (2005)
10.1093/TOXSCI/60.1.177
Single-dose toxicity study of hepatic intra-arterial infusion of doxorubicin coupled to a novel magnetically targeted drug carrier.
S. Goodwin (2001)
10.1002/JPS.2600780406
Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.
P. Gupta (1989)
10.1002/JBM.820280809
Magnetically directed poly(lactic acid) 90Y-microspheres: novel agents for targeted intracavitary radiotherapy.
U. Häfeli (1994)
10.1021/LA061834J
Synthesis of biocompatible poly[2-(methacryloyloxy)ethyl phosphorylcholine]-coated magnetite nanoparticles.
J-J Yuan (2006)
10.1002/JBM.B.30752
Bone tissue engineering with human mesenchymal stem cell sheets constructed using magnetite nanoparticles and magnetic force.
K. Shimizu (2007)
Magnetic albumin microspheres in drug delivery. Microspheres Drug Ther: Pharm, Immunol
KJ Widder (1984)
Organ specifi c application of drugs using cellular capsule systems
U Zimmermann (1976)
Very good review of principles of magnetic drug and nucleic acid delivery discussing the facts and potentials of the technique for research and therapeutic applications
10.1063/1.325219
Magnetic guidance of drug‐carrying microspheres
A. Senyei (1978)
EXPERIMENTAL APPROACH IN THE USE AND MAGNETIC CONTROL OF METALLIC IRON PARTICLES IN THE LYMPHATIC AND VASCULAR SYSTEM OF DOGS AS A CONTRAST AND ISOTOPIC AGENT.
P. Meyers (1963)
10.1096/fj.04-2747rev
Nanomedicine: current status and future prospects
S. Moghimi (2005)
10.3109/02652049609026014
Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique.
T. Mandal (1996)
ERYTHROCYTES BASED DELIVERY OF ISONIAZID : PREPARATION AND IN-VITRO CHARACTERIZATION
S. Jain (1995)
10.1016/J.IJPHARM.2006.10.006
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate.
H. Ma (2007)
Review Biodegradation of surgical polymers
D. F. Williams (1982)
10.1002/(SICI)1098-2299(199606)38:2<125::AID-DDR7>3.0.CO;2-L
Comparative study of the association of itraconazole with colloidal drug carriers
Stéphanie de Chasteigner (1996)
10.1002/mrm.20477
Positive contrast magnetic resonance imaging of cells labeled with magnetic nanoparticles
C. Cunningham (2005)
10.2214/AJR.152.1.167
Superparamagnetic iron oxide: pharmacokinetics and toxicity.
R. Weissleder (1989)
10.1021/mp7001285
Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats.
Tapan Jain (2008)
10.3109/02652049409040435
Preparation and in vitro characterization of a magnetically responsive ibuprofen-loaded erythrocytes carrier.
S. Vyas (1994)
Biomedical applications of magnetic fl uids
Y Morimoto (1980)
USA) assignee. Magnetophoretic particles and apparatus for delivery of substances into cells. Application: US, US patent 94-319521
(1996)
10.1096/fj.06-8070com
Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles
M. Chorny (2007)
10.2174/157341308784340886
Magnetic Driven Alginate Nanoparticles for Targeted Drug Delivery
G. Ciofani (2008)
10.1038/sj.gt.3302159
Dextran–spermine polycation: an efficient nonviral vector for in vitro and in vivo gene transfection
H. Hosseinkhani (2004)
10.1021/NL052241G
Proteolytic surface functionalization enhances in vitro magnetic nanoparticle mobility through extracellular matrix.
S. Kuhn (2006)
10.1016/J.IJPHARM.2003.03.002
Magnetically modulated therapeutic systems.
U. Häfeli (2004)
10.1081/LPR-120017486
Magnetofection: Enhancing and Targeting Gene Delivery with Superparamagnetic Nanoparticles and Magnetic Fields
C. Plank (2003)
10.1021/MA0707584
Controlled pulsatile drug release from a ferrogel by a high-frequency magnetic field
S. Hu (2007)
10.1038/sj.gt.3302534
Nuclear entry of nonviral vectors
D. Dean (2005)
inventors; (USA) assignee. Magnetophoretic particles and apparatus for delivery of substances into cells
AR Kuehnle (1996)
inventors; (Toda Kogyo Corp, Japan) assignee. Needle-like ferric oxide or iron hydroxyoxide granulated material, its manufacture, and manufacture of magnetic iron oxide powder for magnetic recording
K Yamashita (1993)
The degradation and biocompatibility of suture materials
CC Chu (1985)
New ferrocarbon adsorbents for magnetically guided transport of anticancer drugs
AA Kuznetsov (1999)
Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique
Quai Ernest-Ansermet (1998)
10.1016/0378-5173(96)04539-5
Cytotoxicity of magnetite-loaded polylactide, polylactide/glycolide particles and solid lipid nanoparticles
R. Mueller (1996)
10.1016/j.biomaterials.2008.07.004
Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging.
Tapan Jain (2008)
10.1021/MP0500014
Iron oxide nanoparticles for sustained delivery of anticancer agents.
Tapan Jain (2005)
10.3109/02652049609026040
Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of zidovudine.
T. Mandal (1996)
10.1038/sj.gt.3302803
Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo
S. Xenariou (2006)
10.1161/CIRCULATIONAHA.105.001446
Magnetic Forces Enable Rapid Endothelialization of Synthetic Vascular Grafts
S. Pislaru (2006)
10.1186/1477-044X-5-2
Process and formulation variables in the preparation of injectable and biodegradable magnetic microspheres
H. Zhao (2007)
10.1016/J.IJPHARM.2005.06.024
Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles.
L. Ngaboni Okassa (2005)
10.1089/10430349950016816
Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection.
M. E. Barry (1999)



This paper is referenced by
10.15407/FZ58.03.085
Evaluation of biological effects and possible mechanisms of action of static magnetic field
Chekhun Vf (2012)
10.1007/S11051-009-9761-4
Design and fabrication of non-superparamagnetic high moment magnetic nanoparticles for bioapplications
Punnapob Punnakitikashem (2010)
10.1007/S11595-011-0252-Y
Properties of biogenic magnetite nanoparticles in the radula of chiton Acanthochiton rubrolineatus lischke
Chuanlin Liu (2011)
10.4018/978-1-5225-4781-5.CH007
Magnetic Nano-Systems in Drug Delivery and Biomedical Applications
Saritha Shetty (2018)
10.1021/acsnano.9b05660
Use of Oppositely-Polarized External Magnets to Improve the Accumulation and Penetration of Magnetic Nanocarriers into Solid Tumors.
J. F. Liu (2019)
10.1007/s12013-019-00874-5
Externally Controlled Cellular Transport of Magnetic Iron Oxide Particles with Polysaccharide Surface Coatings
K. Cho (2019)
10.1002/adtp.202000061
Magnetic Fluid Hyperthermia Based on Magnetic Nanoparticles: Physical Characteristics, Historical Perspective, Clinical Trials, Technological Challenges, and Recent Advances
H. Etemadi (2020)
10.1002/ADFM.201504176
Magnetic‐Nanoparticle‐Based Immunoassays‐on‐Chip: Materials Synthesis, Surface Functionalization, and Cancer Cell Screening
Y. Zhu (2016)
10.1002/9780470622551.CH5
Microfluidic Devices for Nanodrug Delivery
C. Kleinstreuer (2010)
10.1039/c7sc01462g
Magnetic control of cellular processes using biofunctional nanoparticles
Cornelia Monzel (2017)
10.1002/9781119041559.CH15
Eco-friendly polymer-based nanocomposites for pharmaceutical applications
I. I. Muhamad (2015)
10.1039/c5nr05500h
Magnetically actuated tissue engineered scaffold: insights into mechanism of physical stimulation.
Yulia Sapir-Lekhovitser (2016)
10.1016/j.jconrel.2019.03.031
A review of magnet systems for targeted drug delivery.
Ya-li Liu (2019)
10.1080/07391102.2017.1337592
Interaction of a flavone loaded on surface-modified dextran-spooled superparamagnetic nanoparticles with β-cyclodextrin and DNA
Y. Sameena (2018)
10.1016/j.smaim.2020.04.001
Nanoparticle-based drug delivery systems for cancer therapy
Yu Dang (2020)
10.1007/s41048-020-00117-8
Stimuli-responsive polymeric nanomaterials for rheumatoid arthritis therapy
Yingsi Xie (2020)
10.1021/am101196v
Composite polymeric magnetic nanoparticles for co-delivery of hydrophobic and hydrophilic anticancer drugs and MRI imaging for cancer therapy.
A. Singh (2011)
10.1039/C6RA25826C
Electrochemical design of a new nanosensor based on cobalt nanoparticles, chitosan and MWCNT for the determination of daclatasvir: a hepatitis C antiviral drug
S. M. Azab (2017)
10.1007/978-81-322-2473-0_9
Bionanocomposites for Magnetic Removal of Water Pollutants
F. L. Sousa (2015)
10.2217/nnm.09.109
Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields.
M. Pickard (2010)
CYTOTOXICITY OF BIODEGRADABLE MAGNETIC NANOCOMPOSITE SPHERES FOR DRUG DELIVERY PURPOSES
Anusha Garikapati (2010)
Innovative Magnetic Scaffold Approaches For Osteochondral Defect
Maurilio Marcacci (2011)
10.1039/C0SM00534G
Nanoparticles with targeting, triggered release, and imaging functionality for cancer applications
Kristin H. Loomis (2011)
10.1039/c0lc00656d
Cell sorting by endocytotic capacity in a microfluidic magnetophoresis device.
D. Robert (2011)
10.1021/nl503654t
Dynamic Inversion Enables External Magnets To Concentrate Ferromagnetic Rods to a Central Target
A. Nacev (2015)
10.1039/d0nj01163k
NiFe2O4/poly(ethylene glycol)/lipid–polymer hybrid nanoparticles for anti-cancer drug delivery
K. Joshy (2020)
10.1016/B978-0-08-100716-7.00009-X
Magnetic nanoparticle synthesis
I. Baker (2018)
Open challenges in magnetic drug
Silvia Muro (2014)
10.1134/S0006297910070023
“Smart” liposomal nanocontainers in biology and medicine
Y. Tarahovsky (2010)
10.1016/J.APSUSC.2019.07.215
Janus arrangement of smart polymer on magnetite nanoparticles through solvent evaporation from emulsion droplets
S. Khoee (2019)
10.1016/j.jconrel.2015.09.039
Magnetic nanoparticles and nanocomposites for remote controlled therapies.
Anastasia K. Hauser (2015)
10.2217/nnm.15.159
Nanomedical innovation: the SEON-concept for an improved cancer therapy with magnetic nanoparticles.
S. Lyer (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar